関連する実験動画
Updated: Jul 4, 2026

07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
缺血性心臓病を模倣した心臓水性症候群:症例報告
Andres Chaponan-Lavalle1, Cherie Quiroz Cortegana2, Luis Ivan Gordillo Velasquez2
1Universidad Peruana de Ciencias Aplicadas, Lima, Peru.
IDCases
|February 20, 2026
まとめ
囊性赤内球症 (Cystic echinococcosis,CE) は心臓をめったに罹患させないが,大きな課題をもたらす. 手術による切除と薬剤による治療は,ペルーの女性の心臓のヒダチドキストを成功裏に治療し,流行地域における意識の必要性を強調しました.
科学分野:
- 心臓病学 心臓病学
- 寄生虫学とは,寄生虫学である.
- 感染症 感染症は感染症です.
背景:
- *Echinococcus granulosus*によって引き起こされるシスティックエキノココシス (CE) は,動物性寄生虫性感染症である.
- CEにおける心臓の関与はまれ (症例の<2%),しかし臨床的に有意であり,管理することが困難である.
- 早期の診断と治療は,心臓のCEにおいて好ましい結果を得るために極めて重要です.
研究 の 目的:
- 心臓性システィックエキノコッコ症のまれな症例を報告するためです.
- 心臓ヒダチドーシスの診断と管理戦略を強調する.
- 心臓の質量および関連する症状を有する患者のCEを考慮する重要性を強調する.
主な方法:
- 44歳の女性のケーススタディで,筋力による胸痛とEKGの異常があった.
- 診断画像は,左心室にシスティック質量を明らかにしました.
- ウェスタン・ブロットの血清検査でCEが確認され,その後は外科的切除とアルベンダゾール療法が行われました.
主要な成果:
- 左心室の壁に,カルシフィケーションを伴う多部位型の大きなシスティック・マスが確認されました.
- 組織病理学では,生命力のないヒダチドシスタが確認されました.
- 患者は事件のない回復を経験し,16ヶ月のフォローアップで無症状のままでした.
結論:
- 心臓ヒダチドーシスは,アンギナのような症状と心臓の質量を持つ患者のために,流行地域では考慮されるべきです.
- 外科手術と抗寄生虫薬を含む多学科的な管理は効果的です.
- 公衆の意識と医療教育の向上は,心臓のCEの管理を改善するために不可欠です.
関連する概念動画
Ischemic Heart Disease: Overview
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

